The McGill University Health Centre’s Liquid Biopsy Centre (LBC) was established in 2018 by Dr. Richard Kremer and Dr. Catalin Mihalcioiu. Through the support of the Research Institute of the MUHC (RI-MUHC) and industry partners, Drs. Kremer and Mihalcioiu developed a patented method for liquid biopsy used at the LBC.
Our technology was further refined through grant support from a consortium at the CQDM, including AstraZeneca, Boehringer Ingelheim, GSK, Lilly, Merck, Pfizer, Business-Led Networks of Centres of Excellence (BL-NCE), and the Ministère de l'Économie et de l'Innovation (MEI).
Our Centre is at the forefront of precision medicine research in Canada and conducts specialized collection and analysis of circulating bone, tumour, and immune cells.